Company
PeproMene Bio, Inc.
PeproMene Bio, Inc. has 1 drug tracked on RxWires: 1 in Phase 1.
Pipeline
| Drug | Phase | Indication |
|---|---|---|
| BAFFR-CAR T cells | Phase 1 | Relapsed or Refractory B-cell Non-Hodgkin's Lymphoma |
Latest
No recent events.
Follow PeproMene Bio, Inc. on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.